| Subject: | Second Update of FDA Preliminary Public Health Notification: Guidant VENTAK PRIZM 2 DR and CONTAK RENEWAL Implantable Cardioverter Defibrillators |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 5 Jan 2006 - 10:00 am |
| The FDA has issued a second update of its Preliminary Public Health Notification regarding malfunctions occurring with Guidant VENTAK PRIZM 2 DR and CONTAK RENEWAL Implantable Cardioverter Defibrillators, which were the subjects of a Class I recall announced by the Food and Drug Administration (FDA) on July 1, 2005.
The information provided in this updated PPHN does not change FDA's earlier recommendations about clinical management of patients with these devices, rather it is intended to... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
